metaproterenol has been researched along with Urination Disorders in 2 studies
Metaproterenol: A beta-2 adrenergic agonist used in the treatment of ASTHMA and BRONCHIAL SPASM.
orciprenaline : A racemate composed of equimolar amounts of (R)- and (S)-orciprenaline. Used (as its sulfate salt) to relax the airway muscles and improve breathing for patients suffering from asthma or bronchitis.
5-[1-hydroxy-2-(isopropanylamino)ethyl]benzene-1,3-diol : A member of the class of resorcinols bearing an additional 1-hydroxy-2-(isopropanylamino)ethyl substituent at position 5 of resorcinol itself.
Urination Disorders: Abnormalities in the process of URINE voiding, including bladder control, frequency of URINATION, as well as the volume and composition of URINE.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fiorentini, L | 1 |
Aragona, F | 1 |
van der Bijl, WJ | 1 |
2 other studies available for metaproterenol and Urination Disorders
Article | Year |
---|---|
[Urinary retention following the use of beta-stimulating agents in obstetrics: physiopathological considerations and description of a case].
Topics: Adrenergic beta-Agonists; Adult; Female; Humans; Metaproterenol; Obstetric Labor, Premature; Pregnan | 1980 |
[3 case reports].
Topics: Adolescent; Adrenocorticotropic Hormone; Adult; Aged; Asthma; Child; Ethics, Medical; Humans; Male; | 1971 |